We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Health Risks After Surgery May Last for Years

By HospiMedica staff writers
Posted on 26 Jun 2006
Surgery patients may carry an increased risk of cardiovascular diseases and possibly cancer for weeks or even years, reported scientists studying the unintended effects of surgery.

A few studies have been done across the broad spectrum of the topic, including whether short-term surgical complications, such as infections or pulmonary problems, predict an increase in long-term complications, and whether mutations in genes involved in inflammation result in higher stroke rates after cardiopulmonary bypass surgery. More...
These studies are providing mounting evidence that there are short-term and long-term increased risks, particularly for surgery patients with serious underlying disease, said Dr. Steffen E. Meiler, an anesthesiologist and vice chair for research in the department of anesthesiology and perioperative medicine at the Medical College of Georgia (MCG, Augusta, USA). The remarks were made during a lecture given by Dr. Meiler at the 53rd annual meeting of the Japanese Society of Anesthesiologists, held in Kobe (Japan) in June 2006.

Inflammation is a player in most major diseases, as is body temperature. If the core temperature of patients during surgery drops below 36?C, the complication rate from postoperative infections for certain surgical procedures may be as high as threefold. Infections and even cancer are also concerns post-surgically, as are blood transfusions and apparently volatile anesthetics that actually suppress the immune response. However, studies have shown that taking drugs such as statins and beta blockers can protect against some of this risk.

"The first insight we take away from this is that when bad things happen down the road, months, maybe even years later, that we cannot, as we have in the past, just attribute it to the natural course of illness,” said Dr. Meiler. "Giving beta blockers, statins, making sure your blood sugar doesn't rise during surgery, minimizing blood transfusions, these are all things that we have not paid enough attention to.”



Related Links:
Medical College of Georgia

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.